Decreased mRNA Expression of Two FOXP3 Isoforms in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Free accessResearch articleFirst published online January, 2011
Decreased mRNA Expression of Two FOXP3 Isoforms in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Both the number and functional capacity of T-regulatory (Treg) cells are known to be decreased in various autoimmune diseases. FOXP3, an essential transcription factor for Treg cells, has three isoforms in humans, wild, and exon 2- and exon 2-exon 7-lacking, although their role in autoimmunity is not clearly understood. Here, we investigated the messenger RNA (mRNA) expression of the major wild and exon-2 isoforms in peripheral mononuclear cells by quantitative PCR methods in 56 subjects, consisting of 23 rheumatoid arthritis (RA) and 25 systemic lupus erythematosus (SLE) patients, and 8 healthy controls (HCs). Although mRNA expression of the two isoforms did not directly correlate with clinical disease activity, relative expression of both was significantly lower in SLE and RA patients than in HCs. Furthermore, we found a significant statistical correlation between the two isoforms, suggesting that they are similarly regulated. Decreased expression of these isoforms in RA and SLE may reflect Treg cell abnormalities in these autoimmune diseases.
SakagjuchiS. Regulatory T cells: key controllers of immunologic self-tolerance. Cell2000; 101:455–8.
2.
La CavaA. T-regulatory cells in systemic lupus erythematosus. Lupus2008; 17:421–5.
3.
CostantinoCMBaecher-AllanCMHaflerDA. Human regulatory T cells and autoimmunity. Eur J Immunol2008; 38:921–4.
4.
WanYYFlavellRA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature2007; 445:766–70.
5.
UsmithELFinneyHMNesbittAMRamsdellFRobinsonMK. Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation. Immunology2006; 119:203–11.
6.
MailerRKFalkKRötzschkeO. Absence of leucine zipper in the natural. FOXP3 Delta2 Delta7 isoform does not affect dimerization but abrogates suppressive capacityPLoS One2009; 4:6104.
7.
CampbellDJZieglerSF. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol2007; 7:305–10.
8.
AllanSEPasseriniLBacchettaRCrellinNDaiMOrbanPCZieglerSFRoncaroloMGLevingsMK. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest2005; 115:3276–84.
9.
SmithELFinneyHMNesbittAMRamsdellFRobinsonMK. Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation. Immunology2006; 119:203–11.
10.
ArnettFCEdworthySMBlochDA. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988; 31:315–24.
11.
HochbergMC. The Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40:1725.
12.
PrevooMLvan't HofMAKuperHHvan LeeuwenMAvan de PutteLBvan RielPL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum1995; 38:44–8.
13.
BombardierCGladmanDDUrowitzMBCaronDChangCH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum1992; 35: 630–40.
14.
van AmelsfortJMJacobsKMBijlsmaJWLafeberFPTaamsLS. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum2004; 50:2775–85.
15.
CaoDvan VollenhovenRKlareskogLTrollmoCMalmströmV. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther2004; 6:335–46.
16.
MiyaraMAmouraZParizotC. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol2005; 175:8392–400.
17.
Alvarado-SánchezBHernández-CastroBPortales-PérezDBarandaLLayseca-EspinosaEAbud-MendozaCCubillas-TejedaACGonzález-AmaroR. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun2006; 27:110–8.
18.
SarkarSFoxDA. Regulatory T cell defects in rheumatoid arthritis. Arthritis Rheum2007; 56:710–3.
19.
BonelliMSavitskayaASteinerCWRathESmolenJSScheineckerC. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol2009; 182:1689–95.
20.
HabibagahiMHabibagahiZJaberipourMAghdashiA. Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus. Rheumatol Int2010.
21.
BarretoMFerreiraRCLourençoL. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants. BMC Immunol2009; 27:10–5.
22.
AtfyMAmrGEElnaggarAMLabibHAEshAElokelyAM. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus. Egypt J Immunol2009; 16:117–26.
23.
RyderLRWoetmannAMadsenHOØdumNRyderLPBliddalHDanneskiold-SamsøeBRibel-MadsenSBartelsEM. Expression of full-length and splice forms of FoxP3 in rheumatoid arthritis. Scand J Rheumatol2010; 39:279–86.
24.
OlivitoBSimoniniGCiulliniS. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis. J Rheumatol2009;36: 2017–24.
